is a drug that is classified as a direct thrombin inhibitor.  Direct thrombin inhibitors slow or prevent the body’s production of thrombin, which is a protein that is essential to the formation of blood clots.  The formation of thrombins is the body’s first step in the process known scientifically as the coagulation cascade, through which the body quickly forms a network of tiny fibers that stem the flow of blood from an injured vessel.  This process is triggered by dabigatran etexilate mesylate, the active ingredient in Pradaxa.

Previous ArticleTreatment of Gestational Diabetes Next ArticleFirst Pradaxa Lawsuits Have Now Been Filed
Verdicts and Settlements
Newsletter
Contact Us

Subscribe Now!

[contact-form-7 404 "Not Found"]

Follow Us!

Unsafe Drugs has numerous resources on drug side effects,nutritional supplements, vitamins, and health products.

Site best viewed in Google Chrome, Firefox, Opera, Safari, IE browsers